SERRA, SARA
 Distribuzione geografica
Continente #
NA - Nord America 1.934
EU - Europa 1.247
AS - Asia 737
AF - Africa 58
SA - Sud America 12
OC - Oceania 10
Totale 3.998
Nazione #
US - Stati Uniti d'America 1.909
CN - Cina 471
IT - Italia 458
SE - Svezia 140
IE - Irlanda 132
KR - Corea 121
AT - Austria 95
UA - Ucraina 87
FR - Francia 85
DE - Germania 66
FI - Finlandia 54
SN - Senegal 53
GB - Regno Unito 32
IN - India 32
VN - Vietnam 29
JP - Giappone 25
CA - Canada 24
BE - Belgio 17
PL - Polonia 17
TW - Taiwan 13
HK - Hong Kong 11
SG - Singapore 11
CZ - Repubblica Ceca 10
ES - Italia 10
IR - Iran 10
NL - Olanda 10
AU - Australia 9
BY - Bielorussia 8
CH - Svizzera 8
AR - Argentina 5
EG - Egitto 5
BR - Brasile 4
DK - Danimarca 4
UZ - Uzbekistan 4
SK - Slovacchia (Repubblica Slovacca) 3
GR - Grecia 2
HU - Ungheria 2
PH - Filippine 2
TH - Thailandia 2
UY - Uruguay 2
BG - Bulgaria 1
EC - Ecuador 1
HR - Croazia 1
IL - Israele 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 3.998
Città #
Chandler 335
Beijing 233
Torino 192
Ashburn 137
Dublin 132
Vienna 94
Ann Arbor 90
Fairfield 88
Houston 77
Nyköping 76
Villeurbanne 66
Wilmington 61
Dearborn 50
Centro 45
Princeton 45
Medford 42
Woodbridge 41
Cambridge 39
Fremont 38
Redwood City 38
New York 36
Jacksonville 35
Guangzhou 32
Seattle 32
Milan 31
Shanghai 31
Pisa 26
Nanjing 22
Dong Ket 21
San Mateo 21
Boston 20
Boardman 17
Warsaw 15
Brussels 14
Turin 14
Bologna 11
Düsseldorf 10
Garessio 9
Taipei 9
Toronto 9
Ottawa 8
Chengdu 6
Columbus 6
Fuzhou 6
Hamburg 6
Nanchang 6
Norwalk 6
Shenyang 6
Tianjin 6
Tokyo 6
Wuhan 6
Des Moines 5
Hangzhou 5
Hefei 5
Kunming 5
Los Angeles 5
Phoenix 5
Wenzhou 5
Xian 5
Ancona 4
Birmingham 4
Brisbane 4
Delhi 4
Falls Church 4
Geneve 4
Genova 4
Jinan 4
Leiden 4
Munich 4
Paris 4
Singapore 4
Stockholm 4
Washington 4
Austin 3
Barcelona 3
Berbenno Di Valtellina 3
Bratislava 3
Brescia 3
Brookline 3
Central District 3
Chennai 3
Heidelberg 3
Karaj 3
La Jolla 3
Marche 3
Mountain View 3
Nagoya 3
Prague 3
San Diego 3
San Jose 3
Tappahannock 3
Tucson 3
Adrogue 2
Alexandria 2
Algete 2
Amsterdam 2
Athens 2
Berlin 2
Bradford 2
Budoia 2
Totale 2.571
Nome #
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 664
Mutations in NOTCH1 PEST-domain orchestrate CCL19-driven homing of Chronic Lymphocytic Leukemia cells by modulating the tumor suppressor gene DUSP22 264
The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 222
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 214
The PD-1/PD-L1 axis contributes to T cell dysfunction in chronic lymphocytic leukemia. 171
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response 155
Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts 154
Targeting metabolism and survival in chronic lymphocytic leukemia and richter syndrome cells by a novel NF-κB inhibitor 134
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia 132
SLAMF1/CD150 IS A SIGNALING RECEPTOR EXPRESSED BY A SUBSET OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS CHARACTERIZED BY A FAVORABLE PROGNOSIS 112
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 111
THE PD-1/PD-L1 AXIS CONTRIBUTES TO T CELL DYSFUNCTION IN CHRONIC LYMPHOCYTIC LEUKEMIA 106
CD73-Generated Extracellular Adenosine Creates Microenvironmental Conditions Favoring Growth and Survival of Chronic Lymphocytic Leukemia Cells 106
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment 105
NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model. 99
Slamf-1/CD150 Is a Signaling Receptor Expressed by a Subset of Chronic Lymphocytic Leukemia Patients Characterized by a Favorable Prognosis 91
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death 89
Adenosine Signaling Mediates Hypoxic Responses in the Chronic Lymphocytic Leukemia Microenvironment 84
A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes. 81
Abstract 2302: The extracellular form of NAMPT contributes to creating a proinflammatory environment in chronic lymphocytic leukemia 80
Targeting the Adenosinergic Axis in the Eμ-TCL1 Chronic Lymphocytic Leukemia Mouse Model Offers Novel Therapeutic Opportunities 76
The PD-1/PD-L1 Axis Contributes to T Cell Dysfunction in Chronic Lymphocytic Leukemia 75
The hidden life of NAD+-consuming ectoenzymes in the endocrine system. 70
SLAMF1/CD150 Activates Autophagy in Chronic Lymphocytic Leukemia Cells, Modulating Chemotaxis and Responses to Therapy 70
Mutations in NOTCH1 PEST Domain Orchestrate CCL19-Driven Homing of Chronic Lymphocytic Leukemia (CLL) Cells By Modulating the Gene DUSP22 68
The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting. 67
Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism 66
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia. 63
CD38 signals up-regulate expression and functions of matrix metalloproteinase-9 in chronic lymphocytic leukemia cells. 60
Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia. 59
Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states. 58
Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options. 53
Novel richter syndrome xenograft models to study genetic architecture, biology, and therapy responses 47
PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics. 45
The PD-1/PD-L1 axis contributes to T cell dysfunction in chronic lymphocytic leukemia 41
HPLC-based assay to monitor extracellular nucleotide/nucleoside metabolism in human chronic lymphocytic leukemia cells 39
Targeting of the A2A adenosine receptor counteracts immunosuppression in vivo in a mouse model of chronic lymphocytic leukemia 37
Totale 4.168
Categoria #
all - tutte 10.283
article - articoli 0
book - libri 0
conference - conferenze 2.767
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.050


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019128 0 0 0 0 0 0 0 0 0 39 56 33
2019/2020471 16 8 11 60 29 77 49 40 34 78 41 28
2020/2021555 41 48 20 24 85 23 49 31 98 54 35 47
2021/2022666 42 27 30 62 18 87 47 22 20 70 154 87
2022/2023837 94 106 25 100 61 196 45 39 94 26 25 26
2023/2024427 60 75 33 16 47 73 11 80 12 20 0 0
Totale 4.168